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Genetic manipulation of the RNA genomes by reverse genetics is a powerful tool to study the molecular biology and pathogenesis of RNA
viruses. During construction of an infectious clone from a Vero cell-adapted coronavirus infectious bronchitis virus (IBV), we found that a G–C
point mutation at nucleotide position 15526, causing Arg-to-Pro mutation at amino acid position 132 of the helicase protein, is lethal to the
infectivity of IBVon Vero cells. When the in vitro-synthesized full-length transcripts containing this mutation were introduced into Vero cells, no
infectious virus was rescued. Upon correction of the mutation, infectious virus was recovered. Further characterization of the in vitro-synthesized
full-length transcripts containing the G15526C mutation demonstrated that this mutation may block the transcription of subgenomic RNAs.
Substitution mutation of the Arg132 residue to a positively charged amino acid Lys affected neither the infectivity of the in vitro-synthesized
transcripts nor the growth properties of the rescued virus. However, mutation of the Arg132 residue to Leu, a conserved residue in other
coronaviruses at the same position, reduced the recovery rate of the in vitro-synthesized transcripts. The recovered mutant virus showed much
smaller-sized plaques. On the contrary, a G–C and a G–A point mutations at nucleotide positions 4330 and 9230, respectively, causing Glu–Gln
and Gly–Glu mutations in or near the catalytic centers of the papain-like (Nsp3) and 3C-like (Nsp5) proteinases, did not show detectable
detrimental effect on the rescue of infectious viruses and the infectivity of the rescued viruses.
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Coronaviruses cause severe diseases affecting human and
other animal species. In 2003, a novel coronavirus (SARS-
CoV) was identified as the causative agent of severe acute
respiratory syndrome (SARS) (Marra et al., 2003; Rota et al.,
2003). The potential risk to public health posed by SARS-CoV
and other coronaviruses and the lack of specific antiviral agents
and vaccines have triggered a global research effort to
characterize this family of viruses at the molecular and cellular
levels. Major advances in studies of the biological functions of
individual viral proteins and replication mechanisms are⁎ Corresponding author. Institute of Molecular and Cell Biology, 61 Biopolis
Drive, Proteos, 138673 Singapore.
E-mail address: dxliu@imcb.a-star.edu.sg (D.X. Liu).
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doi:10.1016/j.virol.2006.08.020currently being made by genetic manipulation of coronaviral
genomes using reverse genetics and targeted recombination
approaches (Almazan et al., 2000; Casais et al., 2001, 2003,
2005; Coley et al., 2005; Hodgson et al., 2006; Koetzner et al.,
1992; Masters and Rottier, 2005; Sanchez et al., 1999; Thiel et
al., 2001; Youn et al., 2005a, 2005b; Yount et al., 2000, 2002,
2003, 2005).
Avian infectious bronchitis virus (IBV), a group 3 corona-
virus, causes an acute and contagious disease in chickens with a
significant impact on the poultry industry worldwide. IBV
contains a 27.6 kb single-stranded, positive-sense RNA
genome. In the virus-infected cells, six mRNA species,
including the genome-length mRNA 1 and five subgenomic
mRNAs (mRNA 2–6), are produced by a discontinuous RNA
transcription mechanism. Each mRNA species possesses a 64
nucleotides leader sequence derived from the 5′ end of the
137S. Fang et al. / Virology 358 (2007) 136–147genome (Boursnell et al., 1987). Subgenomic mRNAs 2, 3, 4,
and 6 encode the four structural proteins, i.e., spike glycoprotein
(S), envelope protein (E), membrane protein (M), and
nucleocapsid protein (N). The 5′ two-third region of mRNA 1
comprises two large ORFs, 1a and 1b, and encodes two
polyproteins. The two polyproteins are proteolytically cleaved
by two virus-encoded proteinases, the papain-like and 3C-like
proteinases, into 15 functional proteins (Nsp2–Nsp16) (Lim
and Liu, 1998a, 1998b; Lim et al., 2000; Liu et al., 1995, 1997,
1998; Ng and Liu, 1998, 2000, 2002; Xu et al., 2001).
Compared to other coronaviruses, Nsp1 is absent in IBV but
Nsp2 is considerably larger (Lim and Liu, 1998a, 1998b; Liu et
al., 1995). In general, IBV shares close similarities in the
genome organization, gene expression, and RNA replication
with other coronaviruses but is non-infectious to human. These
properties make IBVan attractive model system for studying the
biology and pathogenesis of coronavirus.
In construction of an infectious IBV clone by in vitro
assembly of five cloned RT-PCR fragments from a Vero cell-
adapted IBVBeaudette strain, a G–C (G15526C) point mutation
at nucleotide position 15,526 was found to be lethal to theFig. 1. In vitro assembly of full-length cDNA clone derived from a Vero cell-adapt
regions coding for the replicase polyproteins, the structural proteins S, E, M, and N, th
shown are the regions of the five RT-PCR fragments, the T7 promoter at the 5′-end of
cDNA fragments, assembly of the five fragments into a full-length cDNA clone, an
covering IBV sequences from nucleotides 1–5751 (lane 2), 5752–8693 (lane 3),
respectively, were obtained by digestion of corresponding plasmid DNAwith either
(lanes 2–6). Equal amounts of the purified fragments were ligated using T4 DNA ligas
cDNAwas used as templates for generation of the full-length in vitro transcripts, whi
markers, and numbers on the left indicate nucleotides in kilobases.infectivity of IBV on Vero cells. No infectious virus could be
rescued from Vero cells electroporated with in vitro-synthesized
full-length transcripts containing this mutation. As this mutation
causes Arg132–Pro mutation in a domain with unknown
function within the helicase protein (Nsp13), it implies that
this region might play certain roles in the functionality of the
helicase protein. On the contrary, a G–C (G4330C) and a G–A
(G9230) point mutations at nucleotide positions 4330 and 9230,
respectively, causingGlu–Gln andGly–Glumutations in or near
the catalytic centers of the papain-like (Nsp3) and 3C-like
(Nsp5) proteinases, did not impair the infectivity of the in vitro-
synthesized transcripts containing these mutations. Further
characterization of the in vitro-synthesized full-length tran-
scripts containing the G15526C mutation demonstrated that this
mutation blocks the transcription of subgenomic RNAs.
Substitution mutation of the Arg132 residue to a positively
charged amino acid (Lys) affected neither the infectivity of the in
vitro-synthesized transcripts nor the growth properties of the
rescued virus. However, mutation of the Arg132 residue to a
Leu, which is conserved in most of other coronaviruses at the
same position, reduced the viral recovery rate of the in vitro-ed IBV Beaudette strain. (a) Diagram of the genome organization of IBV. The
e accessory proteins 3a, 3b, 5a, and 5b, and the 5′- and 3′-UTR are shown. Also
fragment A, and the 30 As at the 3′-end of fragment E. (b) Preparation of the five
d in vitro transcription of the full-length transcripts. The five cDNA fragments
8694–15,520 (lane 4), 15,521–20,900 (lane 5), and 20,901–27,608 (lane 6),
BsmBI or BsaI, purified from agarose gel, and analyzed on a 0.8% agarose gel
e (lane 7) and analyzed on a 0.4% agarose gel. The in vitro assembled full-length
ch were analyzed on a 0.8% agarose gel (lane 10). Lanes 1, 7, and 9 show DNA
Table 2
Comparison of IBV sequences between Vero cell-adapted strain (p65) and the
cloned fragments
Position (nt) p65 Clone
nt aa nt aa
Nsp2 (p87)
2015 A D G G a
Nsp3 (p195)
4330 G E C Q
4481 C T A N
Nsp5 (3CLP)
9230 G G A E
9701–3 -GTG -G GTG Gb
Nsp6
10,253 G S A N
10,540 G D A N
10,594 G E A K
Nsp8 (p24)
10,942 A T C P
11,362 C H T Y
Nsp13 (helicase)
15,526 G R C P
Nsp14 (p58)
17,033 C D T D
17,674 C S T L
18,195 T Y C H
18,430 C S T F
N
26,398 G A T S
a Unique mutations found only in the cloned fragments.
b Same as the published sequences but different from p65.
138 S. Fang et al. / Virology 358 (2007) 136–147synthesized full-length transcripts. The mutant virus showed
much smaller-sized plaques. This study reveals the essential role
of a domain with previously unassigned functions within the
helicase protein in coronavirus replication.
Results
Construction of a full-length cDNA clone derived from a Vero
cell-adapted IBV Beaudette strain by in vitro assembly of five
RT-PCR fragments
To construct a full-length IBV clone, five fragments (A to
E) spanning the entire IBV genome were obtained by RT-
PCR of total RNA extracted from Vero cells infected with a
Vero cell-adapted IBV Beaudette strain (p65) (Shen et al.,
2003, 2004; Fang et al., 2005). To facilitate the assembly of
the full-length cDNA in vitro, restriction sites for either
BsmBI or BsaI were introduced into both the 5′ and 3′ ends
of the fragments (Fig. 1a). In fragment A, a 19-nucleotide
sequence corresponding to the T7 RNA promoter (Table 1)
was inserted into the 5′ end of the IBV genome to facilitate in
vitro transcription using the T7 polymerase (Fig. 1a). The
primers used to amplify these fragments are listed in Table 1.
The PCR products were purified from agarose gel and cloned
into either pCR-XL-TOPO (Invitrogen) or pGEM-T Easy
(Promage) vectors. For the convenience of digestion using the
restriction enzyme BsmBI, the NheI- and EcoRI-digested
fragment A was subcloned into pKT0 which contains a
BsmBI site 400 bp upstream of the T7 promoter sequence
(Fig. 1a). Two to three independent clones for each construct
were selected for sequencing. The complete sequences of the
five fragments, determined by automated nucleotide sequen-
cing, are summarized in Table 2.
The five fragments were then prepared by digestion of the
corresponding constructs with either BsmBI or BsaI and
purified (Fig. 1b, lanes 2–6). The full-length clone was made
by ligation of the purified fragments in vitro (Fig. 1b, lane 8)
and used as the template for in vitro transcription. The full-
length in vitro-synthesized transcripts were generated using the
mMessage mMachine T7 kit (Ambion, Austin, Tex) (Fig. 1b,
lane 10). As coronavirus N gene transcripts were shown to
enhance the recovery of the rescued virus from the in vitro-
synthesized full-length transcripts (Casais et al., 2001; Youn et
al., 2005a, 2005b; Yount et al., 2000, 2002), the N transcriptsTable 1
Primers used to construct the full-length IBV clone
Clone Primer Nucleotide sequence
A T7-IBV 5′-CGCTAGCTAATACGACTC
IBV-5753R 5′-CGGGATCCGTCTCGCGA
B IBV-5748F 5′-ATTATGGTCTCTGTCGCT
IBV-8694R 5′-GGGTCTCGGCCTCAAAT
C IBV-8689F 5′-CGGGATCCGGTCTCGAG
IBV-15532R 5′-GCAAAAGGTCTCAATGA
D IBV-15511F 5′-CGGGATCCGTGATTCATT
IBV-20930R 5′-ACACCTGCAGATGTAACA
E IBV-20887F 5′-GTTTACACCTCTAATGAG
IBV-27608R 5′-GGAATTCGGTCTCG(T)30Twere generated from a linearized pKT0-IBVN construct
containing IBV N gene and the 3′-UTR region. The full-length
transcripts together with the N transcripts were introduced into
Vero cells by electroporation. However, it was consistently
observed that no infectious virus could be recovered from cells
transfected with the full-length transcripts together with the N
transcripts.
Rescue of infectious virus by correction of a point mutation
(G15526C) located in a domain with unknown function within
the helicase protein (Nsp13)
Sequencing comparison of the five fragments with the Vero
cell-adapted IBV strain (p65, accession no. DQ001339) shows
nucleotide changes at 16 positions (Table 2). Among them, 11Location
ACTATAGGACTTAAGATAGATATTAATA-3′ 1–20
CAACACTCTTAAC-3′ 5737–5753
AGCTATAAGACCG-3′ 5748–5768
TTATCACCTATC-3′ 8673–8694
GCCTACCTTTCAGCG-3′ 8689–8706
ATCAC-3′ 15,511–15,532
GAGACCTTTTGC-3′ 15,511–15,532
TC-3′ 20,911–20,930
ACCATAG-3′ 20,887–20,911
GCTCTAACTCTATACTAGC-3′ 27,589–27,608
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deleterious effects of these mutations on the infectivity of the
full-length clone, correction of some of the mutations was
carried out by site-directed mutagenesis. Three point mutations,
G4330C, G9230A, and G15526C, were chosen based on the
fact that they are located either in or near the catalytic centers of
the two viral proteinases or in a region of the RNA helicase
protein with undefined functions. Four full-length cDNA clones
either with correction of the mutations at all three positions
(rIBV) or combination of two positions (e.g., G4330C contain-
ing G–C mutation at nucleotide position 4330 but without
mutations at the other two positions) were constructed. RNA
transcripts generated from the four full-length cDNA clones
were introduced into Vero cells together with the N transcripts
by electroporation. At 2 days post-electroporation, a typical
CPE of the Vero cell-adapted IBV, the formation of giant
syncytial cells (Fang et al., 2005), was observed in cells
transfected with transcripts generated from cDNA clones rIBV,
G4330C, and G9230A. CPE was extended to almost the whole
monolayers at 3 days post-electroporation (Fig. 2a). No CPEFig. 2. Recovery of infectious viruses from cells electroporated with in vitro-synthesi
transcripts derived from the in vitro assembled full-length clones with or without a
Images were taken at 3 days post-electroporation. (b) Nucleotide sequencing of the le
Vero cells infected with the recombinant virus rescued from the in vitro-synthesized
subgenomic mRNA 5 was amplified by RT-PCR and sequenced by automated nu
sequence (TRS) for mRNA 5 are shown.was observed in cells transfected with transcripts generated
from clone G15526C (Fig. 2a).
RT-PCR analysis of the subgenomic mRNA 5 was
performed to confirm if CPE observed is caused by the
replication of IBV. Sequencing of the RT-PCR fragment
generated from cells transfected with rIBV showed correct
sequence in the leader/body junction region of the subgenomic
mRNA (Fig. 2b). Further sequencing of the RT-PCR fragments
covering regions with unique amino acid mutations confirmed
the recovery of IBV (rIBV) from the in vitro-synthesized full-
length transcripts.
Characterization of the rescued IBV virus (rIBV)
Compared to the parent IBV strains, rIBV contains 8 amino
acid mutations (Table 2). To test if these mutations may affect
the growth properties and genetic stability of the rescued virus,
rIBV was propagated on Vero cells for 5 passages, and the
plaque sizes and growth kinetics were determined and
compared with wild type IBV p65. In cells infected withzed full-length transcripts. (a) Vero cells electroporated with in vitro-synthesized
point mutation at one of the three positions (G4330C, G9230A, or G15526C).
ader/body junction of the subgenomic mRNA 5. Total RNAwas prepared from
full-length transcripts 24 h post-infection. The 5′ 400-nucleotide region of the
cleotide sequencing. The 70 nucleotides flanking the transcription regulatory
Fig. 3. Analysis of the growth properties of wild type (p65) and rIBV. (a) Plague
sizes and one-step growth curves of wild type and rIBV. Monolayers of Vero cells
on a 6-well plate were infected with 100 μl of 1000-fold diluted virus stock and
cultured in the presence of 0.5% carboxymethy cellulose at 37 °C for 3 days. The
cells were fixed and stained with 0.1% toluidine. To determine the one-step growth
curves of wild type and rIBV, Vero cells were infected with the viruses and
harvested at 0, 4, 8, 12, 16, 24, and 36 h post-inoculation, respectively. Viral stocks
were prepared by freezing/thawing of the cells three times, and TCID50 of each
viral stock was determined by infecting five wells of Vero cells on 96-well plates in
triplicate with 10-fold serial dilution of each viral stock. Error bar shows standard
error of the mean. (b) Northern blot analysis of the genomic and subgenomic RNAs
in cells infected with wild type and rIBV. Ten micrograms of total RNA extracted
fromVero cells infectedwithwild type and rIBV, respectively, was separated on 1%
agarose gel and transferred to a Hybond N+ membrane. Viral RNAs were probed
with a Dig-labeled DNA probe corresponding to the 3-end 680 nucleotides of the
IBV genome. Total RNA extracted from mock-infected cells was included as
negative control. Numbers on the left indicate nucleotides in kilobase, and numbers
on the right indicate the genomic and subgenomic RNA species of IBV. (c)Western
blot analysis of viral protein expression in cells infected with wild type and rIBV.
Vero cells infectedwithwild type (lane 1) and rIBV (lane 2) were harvested, lysates
prepared and separated on SDS-10% polyacrylamide gel. The expression of S, N,
and M proteins was analyzed by Western blot with polyclonal anti-S, anti-N, and
anti-M antibodies, respectively. The same membrane was also probed with anti-
actin antibody as a loading control. Numbers on the left indicate molecular masses
in kilodaltons.
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slightly smaller than the average plaque size of 0.68±0.034 mm
in cells infected with wild type IBV (Fig. 3a). Analysis of the
growth curves demonstrated that rIBV exhibited very similar
growth properties as the wild type virus (Fig. 3a).
Further characterization of rIBV was subsequently carried
out by analysis of viral RNAs and structural proteins. Northern
blot and Western blot analyses showed the detection of very
similar amounts of viral RNAs (Fig. 3b), and S, N, and M
proteins (Fig. 3c) in cells infected with wild type and rIBV,
respectively, at 24 h post-infection. When probing with anti-N
protein antibodies, other species migrating faster than the full-
length products on SDS-PAGE were also observed (Fig. 3c).
They may represent premature termination and cleavage
products of N protein (unpublished observation). It was also
noted that variable amounts of these species were detected in
cells infected with wild type and rIBV (Fig. 3c). The
significance of these variations is unclear at the moment.
Taken together, these results confirm that rIBV is stable and
possesses very similar growth properties as wild type IBV.
Absence of subgenomic RNA transcription in cells transfected
with G15526C mutant transcripts
As no infectious virus was recovered from cells transfected
with G15526C mutant transcripts, RT-PCR amplification of the
negative strand RNAwas performed to check if RNA replication
occurred in these transfected cells. Total RNA was extracted
from Vero cells transfected with wild type and G15526C mutant
transcripts at 24 and 48 h post-electroporation, respectively.
Reverse transcription was performed by using equal amount of
RNA and the sense-primer IBV14931-F (5′-14,931GCT-
TATCCACTAGTACATC14,949-3′), and PCR was carried out
by using the sense-primer IBV14931-F and the antisense-primer
IBV15600-R (5′-15,600CTTCTCGCACTTCTGCACTA-
GCA15,578-3′). If replication of viral RNA occurred, a 670 bp
PCR fragment would be expected. As shown in Fig. 4a, RT-PCR
fragments amplified from negative strand RNA templates were
obtained from cells transfected with both wild type (lanes 2 and
4) and the mutant transcripts (lanes 3 and 5). Sequencing of the
PCR fragments confirmed that they represent the correct
sequences. As a negative control, the in vitro-synthesized
transcripts were mixed with total RNA extracted from normal
Vero cells and were used as a template for RT-PCR. No RT-PCR
fragment was detected (Fig. 4a, lane 6), confirming that the
detection of negative strand RNA from cells transfected with
mutant transcripts is due to the replication of viral RNA. Further
quantitation of the negative strand RNA transcription in cells
transfected with wild type and G15526C mutant transcripts was
carried out by real-time PCR. At 24 and 48 h post-electropora-
tion, transcription of the negative RNA in cells electroporated
with wild type transcripts was 24.76- and 945.54-fold,
respectively, higher than that in cells electroporated with the
G15526C mutant transcripts. These results confirm that
transcription of the negative strand RNA has taken place in
cells transfected with the mutant transcripts, but with much
lower efficiency.
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out to check if a low level of subgenomic mRNA synthesis
could occur in cells transfected with the mutant transcripts.Total RNA prepared from the transfected cells 2 days post-
electroporationwas used in theRTreactionwith the sense-primer
IBV-leader (5′-26CTATTACACTAGCCTTGCGCT46-3′) for
the detection of negative-stranded sgRNA, and the antisense-
primer IBV24803-R (5′-24,803CTCTGGATCCAATAACC-
TAC24,784-3′) for the detection of positive-stranded sgRNA.
The two primers were then used for PCR. If transcription of
subgenomic mRNAs did occur, a 415 bp PCR product
corresponding to the 5′-terminal region of the subgenomic
mRNA 4 and a 1010 bp fragment corresponding to the 5′-
terminal region of the subgenomic mRNA 3 would be expected.
As shown in Fig. 4b, a dominant 415 bp band and a weak
1010 bp band were observed in cells electroporated with wild
type full-length transcripts at 2 days post-electroporation (lanes
2 and 5). Sequencing of the PCR fragments confirmed that they
represent the correct sequences of the corresponding regions of
the subgenomic mRNAs 3 and 4, respectively. However, the
same PCR products were not detected in cells electroporated
with the mutant transcripts (Fig. 4b, lanes 3 and 6). As a negative
control, the amplified fragments were not detected in cells
without electroporation (Fig. 4b, lane 4). The failure to detect
both negative- and positive-stranded sgRNAs in cells trans-
fected with the mutant transcripts show that the G15526C
mutation leads to the disruption of subgenomic RNA
transcription.
To further demonstrate that the failure to rescue infectious
virus from the G15526C mutant transcripts is due to a defect in
subgenomic RNA transcription, the full-length clones with and
without the G15526C mutation were used to generate
recombinant IBV expressing the enhanced green fluorescent
protein (EGFP) by replacing the 5a gene with EGFP. Full-length
transcripts containing EGFP were synthesized in vitro and
introduced into Vero cells together with the N transcripts by
electroporation. At 2 days post-electroporation, single CPE with
the expression of EGFP was observed in cells transfected with
the full-length transcripts without the G15526C mutationFig. 4. Analysis of RNA replication in cells electroporated with G15526C
mutant transcripts. (a) Detection of negative strand RNA synthesis in cells
electroporated with wild type (lanes 2 and 4) and G15526C mutant (lanes 3 and
5) transcripts. Total RNA was prepared from Vero cells electroporated with in
vitro-synthesized full-length transcripts at 24 and 48 h post-electroporation,
respectively. Region corresponding to nucleotides 14,931–15,600 of the
negative (−) sense IBV genomic RNAwas amplified by RT-PCR and analyzed
on 1.2% agarose gel. Lane 1 shows DNA markers, and lane 6 shows negative
control. Numbers on the left indicate nucleotides in bases. (b) Detection of the
negative and positive strand subgenomic RNA synthesis in cells electroporated
with wild type (lanes 2 and 5) and G15526C mutant (lanes 3 and 6) transcripts.
Total RNA was prepared from Vero cells electroporated with in vitro-
synthesized full-length transcripts 2 days post-electroporation. Regions
corresponding to the 5′-terminal 415 and 1010 nucleotides of the subgenomic
mRNA 4 and 3, respectively, were amplified by RT-PCR and analyzed on 1.2%
agarose gel. Lane 1 shows DNAmarkers, and lane 4 shows negative cell control.
Numbers on the left indicate the length of DNA in bases. (c) Construction of a
recombinant IBV expressing EGFP and further analysis of the effect of
G15526C mutation on subgenomic transcription using the recombinant virus.
Vero cells electroporated with in vitro-synthesized transcripts derived from the
in vitro assembled full-length clones containing EGFP either with or without
G15526C mutation. Phase-contrast and fluorescent images were taken 2, 3, and
5 days post-electroporation, respectively.
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observed from 3 to 5 days post-electroporation (Fig. 4c). At
5 days post-electroporation, CPE and fluorescent cells were
extended to almost the whole monolayer (Fig. 4c). However, it
was consistently observed that much less infectious virus was
recovered from cells transfected with this construct. Further-
more, the recombinant virus rapidly lost infectivity when
passaged on Vero cells; the recovered virus maintains minor
infectivity only for one passage. In cells transfected with the full-
length transcripts containing the G15526C mutation, neither
CPE nor cells expressing EGFP were observed (Fig. 4c),
demonstrating that G15526C mutation led to total demolition of
the EGFP expression. As EGFP could be expressed only if
subgenomic RNAs were synthesized but can be observed even if
a single cell was transfected and expressed the protein to a
certain level, these results reinforce the conclusion that the
G15526C mutation blocks subgenomic RNA transcription.
Mutational analysis of the R132 residue of the helicase protein
G15526C mutation resulted in the substitution mutation of
the R132 with a Pro (R132P) of the helicase protein. SequenceFig. 5. Mutational analysis of the R132 residue of the helicase protein. (a) Sequence
from seven different coronaviruses. The identical amino acids are shown in bold, a
underlined. Also shown are the R132 residue in IBV and the equivalent amino ac
synthesized transcripts derived from wild type recombinant IBV (rIBV), R132K, R13
post-electroporation.comparison of the IBV helicase protein with other known
coronaviruses showed that R132 residue is located adjacent to a
conserved motif (Fig. 5a). In all sequenced coronaviruses, only
IBV has a charged amino acid (R132) at this position (Fig. 5a).
To assess if a positive charge amino acid at this position is
essential for the function of the protein, mutation of R132 to a
Lys (R132K) was carried out. Meanwhile, a conserved Leu
residue (Ile in the case of TGEV) was found at this position in
all other coronaviruses, mutation of R132 to a Leu (R132L) was
also included.
In vitro full-length transcripts containing the R132K and
R132L mutations were electroporated into Vero cells. As
shown in Fig. 5b, transcripts generated from wild type
(R132) and R132K mutant constructs showed very similar
infectivity after introduction into Vero cells. Typical CPE
was observed in large areas of the monolayers at 3 days
post-electroporation (Fig. 5b), and recombinant viruses were
recovered. However, R132L transcripts were found to be less
infectious. In cells electroporated with transcripts generated
from this mutant, typical CPE was observed in much
restricted areas of the monolayer at 3 days post-electroporation
(Fig. 5b).comparison of the region between amino acids 70 and 140 of helicase proteins
nd the last Cys/His residues of the zinc-binding domain are shown in bold and
ids in other coronaviruses (boxed). (b) Vero cells electroporated with in vitro-
2L, and R132P (G15526C) constructs. Phase-contrast images were taken 3 days
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mutant viruses
The growth properties of the R132K and R132L mutant
viruses on Vero cells were tested by analysis of plaque sizes and
growth curves of passage 5 mutant viruses. Compared to cells
infected with wild type recombinant virus (average plaques size
is 0.56±0.028), plaques with similar size were observed in cells
infected with the R132K mutant virus (Fig. 6a). The average
plaque size in cells infected with R132K mutant virus is
0.59±0.029 mm. In cells infected with the R132L mutant virus,
much smaller-sized plaques were observed (Fig. 6a). The
average plaque size in cells infected with this mutant virus is
0.24±0.017 mm. However, analysis of the growth curves of
wild type and mutant viruses demonstrated that the mutant
viruses exhibited very similar, or even better, growth properties
as the wild type recombinant virus (Fig. 6a).The R132K and R132L mutant viruses were subsequently
characterized by analysis of viral RNAs and structural
proteins. Northern blot analysis showed the detection of
very similar amounts of genomic and subgenomic RNAs in
cells infected with rIBV and the two mutant viruses at 24 h
post-infection (Fig. 6b). Similarly, Western blot analysis of
cells infected with rIBV, R132K, and R132L mutant viruses
showed that similar amounts of S, N, and M proteins were
detected at 24 h post-infection (Fig. 6c, lanes 1–3). When
probing with anti-N protein antibodies, other species migrat-
ing faster than the full-length products on SDS-PAGE were
also observed (Fig. 6c). They may represent premature
termination and cleavage products of N protein (unpublished
observation). It was also noted that variable amounts of these
species were detected in cells infected with wild type and
different mutants (Fig. 6c).
The genetic stability of R132K and R132L mutant viruses
was tested by propagation of the viruses on Vero cells for 5
passages. Sequencing analysis of the fifth passages of the two
mutant viruses showed that the mutations are stable. No
reversion to the original sequences or mutation to other
nucleotides was found in the position.
Discussion
In vitro assembly of full-length coronavirus clones, genera-
tion of full-length transcripts in vitro using a bacteriophage
DNA-dependent RNA polymerase, and recovery of infectious
viruses by introduction of the in vitro-synthesized transcripts
into cells, first used by Yount et al. (2000), are a rapid and
reliable approach to construct infectious clones from large RNA
viruses. It has been successfully used to construct infectiousFig. 6. Analysis of the growth properties of rIBV, R132K, and R132L mutant
viruses. (a) Plague sizes and one-step growth curves of rIBV, R132K, and
R132 mutant viruses. Monolayers of Vero cells on a 6-well plate were
infected with 100 μl of 100-fold diluted virus stock and cultured in the
presence of 0.5% carboxymethy cellulose at 37 °C for 3 days. The cells were
fixed and stained with 0.1% toluidine. To determine the one-step growth
curves of rIBV, R132K, and R132L mutant viruses, Vero cells were infected
with the viruses and harvested at 0, 4, 8, 12, 16, 24, and 36 h post-
inoculation, respectively. Viral stocks were prepared by freezing/thawing of
the cells three times, and TCID50 of each viral stock was determined by
infecting five wells of Vero cells on 96-well plates in triplicate with 10-fold
serial dilution of each viral stock. Error bar shows standard error of the mean.
(b) Northern blot analysis of the genomic and subgenomic RNAs in cells
infected with rIBV, R132K, and R132L mutant viruses. Ten micrograms of
total RNA extracted from Vero cells infected with rIBV, R132K, and R132L
mutant viruses, respectively, was separated on 1% agarose gel and transferred
to a Hybond N+ membrane. Viral RNAs were probed with a Dig-labeled
DNA probe corresponding to the 3-end 680 nucleotides of the IBV genome.
Numbers on the left indicate nucleotides in kilobase, and numbers on the
right indicate the genomic and subgenomic RNA species of IBV. (c) Western
blot analysis of viral protein expression in cells infected with wild type and
R132 mutant viruses. Vero cells infected with wild type recombinant IBV
(lane 1), R132K (lane 2), and R132L (lane 3) were harvested, lysates
prepared, and separated on SDS-10% polyacrylamide gel. The expression of
S, N, and M proteins was analyzed by Western blot with polyclonal anti-S,
anti-N, and anti-M antibodies, respectively. The same membrane was also
probed with anti-actin antibody as a loading control. Numbers on the left
indicate molecular masses in kilodaltons.
144 S. Fang et al. / Virology 358 (2007) 136–147clones for several coronaviruses, including transmissible
gastroenteritis virus (TGEV), mouse hepatitis virus (MHV),
SARS-CoV, and IBV (Youn et al., 2005a, 2005b; Yount et al.,
2000, 2003). In the process of developing an infectious IBV
clone from a Vero cell-adapted IBV Beaudette strain using this
approach, a G–C point mutation at nucleotide position 15,526
was found to be lethal to the infectivity of the in vitro-
synthesized full-length transcripts on Vero cells. No infectious
virus could be rescued from Vero cells electroporated with
transcripts containing this mutation. This mutation causes
Arg132–Pro substitution in a domain within the helicase
protein (Nsp13) with undefined functions, indicating that this
domain may be essential for the functionality of the helicase
protein.
Multiple enzymatic activities have been assigned to the
Nsp13 helicase protein. These include RNA and DNA
duplex-unwinding activities, NTPase and dNTPase activities,
and an RNA 5′-triphosphatase activity that might be involved
in the formation of the 5′-cap structure of viral RNAs (Ivanov
et al., 2004). The protein is comprised of two domains: a
putative N-terminal zinc binding domain, which spans the N-
terminal region of the protein from approximately amino
acids 1 to 77, and a C-terminal helicase domain covering the
C-terminal part of the protein from amino acids 279 to the C-
terminal end (Ivanov et al., 2004). A Ser–Pro substitution
located immediately downstream of the putative zinc binding
domain of Nsp10, the equivalent RNA helicase protein in
equine arteritis virus (EAV), caused defect in subgenomic
mRNA transcription (van Dinten et al., 1997, 2000). More
detailed analysis of the zinc binding domain of Nsp10 from
EAV and Nsp13 from human coronavirus 229E by mutagen-
esis studies showed that this domain could modulate the
enzymatic activities of the helicase domain (Seybert et al.,
2005). Through this regulatory role and some yet to be
discovered mechanisms, the zinc binding domain is shown to
be critically involved in the replication and transcription of
coronavirus RNA.
In this study, introduction of the in vitro-synthesized full-
length transcripts containing the G15526C (R132P) mutation
was shown to be totally defective in subgenomic RNA
transcription, a phenotype similar to, but appears to be much
more severe than, the Ser–Pro mutation in EAV (van Dinten et
al., 1997, 2000). Mutation of the Arg132 residue to a positively
charged amino acid (Lys) does not affect the infectivity of the in
vitro-synthesized transcripts as well as the growth properties of
the rescued virus. However, mutation of the Arg132 residue to
Leu, a conserved residue at the same position in most of other
known coronaviruses, impaired the recovery rate of the in vitro-
synthesized transcripts. The recovered mutant virus showed
much smaller-sized plaques. The R132 residue is located 57
amino acids downstream of the last His (H75) residue in the
putative zinc binding domain (Fig. 5a) and 147 amino acids
upstream of the helicase motif 1 (Seybert et al., 2005). So far, no
functional domain has been found in this region of the helicase
protein.
Why the R132P substitution, located outside of the two
functional domains of the helicase protein, shows severephenotypic defect in subgenomic RNA transcription and the
infectivity of IBV is not clear at the moment. Three possibilities
were considered. First, R132 may be part of the N-terminal zinc
binding domain. As no studies have been attempted to define
the boundary of the two domains, it is not even certain that an
independent domain with unique function may exist in this
region. R132P mutant virus shares certain phenotypic similarity
to the Ser–Pro mutant EAV, such as the absence of subgenomic
mRNA transcription (van Dinten et al., 1997, 2000), suggesting
that the two mutations might disrupt a similar function of the
helicase protein. However, as biochemical characterization of
the effect of R132P mutation on the enzymatic activities of IBV
Nsp13 helicase protein is currently lacking, it would be difficult
to draw a conclusion that the two mutants share mechanistically
similar characteristics. Second, R132 is located in a region with
a high degree of amino acid conservation in all known
coronaviruses. Since the main defect of R132P mutant virus
is in the subgenomic RNA transcription, one possibility is that
this region may be involved in the subgenomic RNA synthesis
by interacting with host or other viral functional proteins.
Alternatively, as a positively charged amino acid is required to
maintain the full function of the protein, it would be possible
that this region may be involved in binding of the helicase
protein to viral RNA during RNA replication and transcription.
Finally, mutation to a Pro would lead to the disruption of the
three dimensional structures of the two domains. Biochemical
characterization of the involvement of this region in the
enzymatic activities of the protein and determination of its
three dimensional structures are underway to address these
possibilities.
The G433C (E–Q) point mutation near the catalytic center of
the PLP domain in Nsp3 affects neither the recovery of
infectious virus from the full-length synthesized in vitro
transcripts nor the infectivity of the rescued virus. Similarly,
efficient recovery of infectious virus from the in vitro transcripts
containing the G9230A (G–E) point mutation in the 3CLP was
obtained. The two mutant viruses are genetically stable and
show similar growth properties with the wild type recombinant
virus. Even though the two mutations are located in or near the
catalytic centers of the two viral proteinases, the mutations did
not alter their enzymatic activities. This relatively high degree
of tolerance to mutations in non-essential regions of important
functional proteins would minimize the occurrence of lethal
mutations during the replication cycles of RNA viruses and
increase the adaptability of these viruses to a changed
environment.
Materials and methods
Cells and virus
Vero cells were cultured at 37 °C in minimal essential
medium (MEM) supplemented with 10% fetal bovine serum
(FBS), penicillin (100 units/ml), and streptomycin (100 μg/ml).
AVero cell-adapted IBV Beaudette strain (65 passages on Vero
cells (p65)) (Shen et al., 2003, 2004; Fang et al., 2005) was
propagated in Vero cells in FBS-free MEM.
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cloning, and sequencing
Five fragments spanning the entire IBV genome were
obtained by RT-PCR from Vero cells infected with the Vero
cell-adapted IBV p65 at a multiplicity of approximately 1.
Briefly, total cellular RNAwas extracted from the infected Vero
cells with TRI Reagent (Molecular Research Center, Inc.),
according to the manufacturer's instructions. Reverse transcrip-
tion was performed with Expand Reverse Transcriptase (Roche)
using reverse primers IBV-5753R, IBV-8694R, IBV-15532R,
IBV-20930R, and IBV-27608R (Table 1). Each cDNA fragment
was amplified from RT products by PCR using KOD Hot Start
DNA polymerase according to the manufacturer's instructions
(Novagen). The PCR products were purified from agarose gels
and cloned into pCR-XL-TOPO (Invitrogen) or pGEM-T Easy
(Promage) vectors. Subsequently, fragment A was removed
from pCR-XL-TOPO by digestion with NheI and EcoRI and
subcloned into pKT0 vector.
Two to three independent clones of each fragment were
selected and sequenced by automated sequencing using specific
primers and the ABI dye termination sequencing method.
Sequence comparison, assembly, and analysis were performed
by using BLAST and DNA STAR software.
PCR mutagenesis
Mutations were introduced into the corresponding fragments
by using QuickChange site-directed mutagenesis kit (Strata-
gene) and confirmed by sequencing of the whole fragments.
In vitro assembly of full-length cDNA clones
Plasmids were digested with either BsmBI (fragment A) or
BsaI (fragments B, C, D, and E). The digested plasmids were
separated on 0.8% agarose gels containing crystal violet. Bands
corresponding to each of the fragments were cut from the gels
and purified with QIAquick gel extraction kit (QIAGEN Inc.).
Fragments A and B, and fragments C, D, and E were first
ligated with T4 DNA ligase at 4 °C overnight. The two reaction
mixtures were then mixed and further ligated at 4 °C overnight.
The final ligation products were extracted with phenol/chloro-
form/isoamyl alcohol (25:24:1), precipitated with ethanol, and
detected by electrophoresis on 0.4% agarose gels.
In vitro transcription and electroporation
Full-length transcripts were generated in vitro using the
mMessage mMachine T7 kit (Ambion, Austin, TX) according
to the manufacturer's instructions with certain modifications.
Briefly, 30 μl of transcription reaction with a 1:1 ratio of GTP to
cap analog was sequentially incubated at 40.5 °C for 25 min,
37.5 °C for 50 min, 40.5 °C 25 min and 37.5 °C for 20 min.
The N transcripts were generated by using a linearized
pKTO-IBVN containing IBV N gene and the 3′-UTR region as
templates. A 1:2 ratio of GTP to cap analog was used for the
transcription of IBV N gene.Introduction of in vitro-synthesized transcripts into Vero cells
by electroporation
The in vitro-synthesized full-length and N transcripts were
treated with DNaseI and purified with phenol/chloroform. Vero
cells were grown to 90% confluence, trypsinized, washed twice
with cold PBS, and resuspended in PBS. RNA transcripts were
added to 400 μl of Vero cell suspension in an electroporation
cuvette and electroporated with one pulse at 450 V, 50 μF with a
Bio-Rad Gene Pulser II electroporator. The transfected Vero
cells were cultured overnight in 1% FBS-containing MEM in a
60 mm dish or a six-well plate and further cultured in MEM
without FBS.
Analysis of the negative strand and subgenomic RNAs
by RT-PCR, real-time PCR
Total RNAwas extracted from Vero cells electroporated in in
vitro-synthesized transcripts after treatment with DNaseI, using
TRI Reagent (Molecular Research Center, Inc.) at 24 or 48 h
post-electroporation. Reverse transcription was performed with
Expand Reverse Transcriptase (Roche) using equal amount of
RNA. After optimization, real-time PCR was performed using
LightCycler FastStart DNAMaster SYBR Green I kit according
to the manufacturer's instructions (Roche).
Northern blot analysis
Vero cells were infected with wild type and mutant viruses
at a multiplicity of approximately 1, and total RNA was
extracted from the infected cells. Ten micrograms of RNA was
added to a mixture of 1× MOPS, 37% formaldehyde, and
formamide and incubated at 65 °C for 20 min before subjected
to gel electrophoresis. The segregated RNA bands were
transferred onto a Hybond N+ membrane (Amersham Bios-
ciences) via capillary action overnight and fixed by UV
crosslinking (Stratalinker). Hybridization of Dig-labeled DNA
probes was carried out at 50 °C in hybridization oven
overnight. Membranes were washed 3 times for 15 min each
with the probe buffer, before proceeding to detection with
CDP-Star (Roche) according to the manufacturer's instructions.
Western blot analysis
Vero cells were infected with wild type and mutant viruses at
a multiplicity of approximately 1. Total proteins extracted from
the infected Vero cells were lysed with 2× SDS loading buffer in
the presence of 200 mMDTT plus 10 mM of iodoacetamide and
subjected to SDS-PAGE. Proteins were transferred to PVDF
membrane (Stratagene) and blocked overnight at 4 °C in
blocking buffer (5% fat free milk powder in PBST buffer). The
membrane was incubated with 1:2000 diluted primary anti-
bodies in blocking buffer for 2 h at room temperature. After
washing three times with PBST, the membrane was incubated
with 1:2000 diluted anti-mouse or anti-rabbit IgG antibodies
conjugated with horseradish peroxidase (DAKO) in blocking
buffer for 1 h at room temperature. After washing three times
146 S. Fang et al. / Virology 358 (2007) 136–147with PBST, the polypeptides were detected with a chemilumi-
nescence detection kit (ECL, Amersham Biosciences) accor-
ding to the manufacturer's instructions.
Growth curve and plaque sizes of the recombinant viruses on
Vero cells
Confluent monolayers of Vero cells on six-well plates were
infected with 100 μl of 100-fold diluted virus stock. After 1 h of
incubation at 37 °C, cells were washed twice with PBS and
cultured in 3 ml of MEM containing 0.5% carboxymethy
cellulose for 3 days. The cells were fixed and stained with 0.1%
toluidine.
Vero cells were infected with wild type and recombinant IBV
and harvested at different times post-infection. Viral stocks were
prepared by freezing/thawing of the cells three times. The 50%
tissue culture infection dose (TCID50) of each sample was
determined by infecting five wells of Vero cells on 96-well
plates in duplicate with 10-fold serial dilution of each viral
stock.
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